Feasibility, results and endoscopic requirements of the Elipse® swallowable intragastric balloon: initial experience.
Eduardo Espinet CollSonia Carrasco ClavijosPatricia Díaz GalánCarmen Vila LoloJosé Antonio Gómez ValeroSilvia BacchidduDaniel IrigoyenTeresa Durán PastorLaura Mora CubellsAntonio Juan-Creix ComamalaPublished in: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (2020)
EIGB placement by x-ray seems feasible and safe. Although some devices have a shorter duration than expected, such as < 16 weeks in 29% patients and < 12 weeks in 8.3% of patients, an acceptable weight loss at four months was obtained. There were some adverse effects that required endoscopy, thus we advise that the procedure be supervised by a bariatric endoscopist.